Global Assessment of Functioning (GAF): properties and frontier of current knowledge.
BACKGROUND
Global Assessment of Functioning (GAF) is well known internationally and widely used for scoring the severity of illness in psychiatry. Problems with GAF show a need for its further development (for example validity and reliability problems). The aim of the present study was to identify gaps in current knowledge about properties of GAF that are of interest for further development. Properties of GAF are defined as characteristic traits or attributes that serve to define GAF (or may have a role to define a future updated GAF).


METHODS
A thorough literature search was conducted.


RESULTS
A number of gaps in knowledge about the properties of GAF were identified: for example, the current GAF has a continuous scale, but is a continuous or categorical scale better? Scoring is not performed by setting a mark directly on a visual scale, but could this improve scoring? Would new anchor points, including key words and examples, improve GAF (anchor points for symptoms, functioning, positive mental health, prognosis, improvement of generic properties, exclusion criteria for scoring in 10-point intervals, and anchor points at the endpoints of the scale)? Is a change in the number of anchor points and their distribution over the total scale important? Could better instructions for scoring within 10-point intervals improve scoring? Internationally, both single and dual scales for GAF are used, but what is the advantage of having separate symptom and functioning scales? Symptom (GAF-S) and functioning (GAF-F) scales should score different dimensions and still be correlated, but what is the best combination of definitions for GAF-S and GAF-F? For GAF with more than two scales there is limited empirical testing, but what is gained or lost by using more than two scales?


CONCLUSIONS
In the history of GAF, its basic properties have undergone limited changes. Problems with GAF may, in part, be due to lack of a research programme testing the effects of different changes in basic properties. Given the widespread use, research-based development of GAF has not been especially strong. Further research could improve GAF.
Aas
I H Monrad
IH
Department of Research, Vestfold Mental Health Care Trust, Tönsberg, Norway. monrad.aas@piv.no
Psychiatr Serv. 2002 Jun;53(6):730-7
12045311
J Child Psychol Psychiatry. 1995 Jul;36(5):787-92
7559845
Acta Psychiatr Scand. 1999 Feb;99(2):135-40
10082189
Acta Psychiatr Scand. 1997 Oct;96(4):254-9
9350953
Br J Psychiatry. 2005 May;186:394-9
15863743
Psychiatr Serv. 2005 Apr;56(4):444-51
15812095
Acta Psychiatr Scand. 1996 Feb;93(2):125-8
8686482
J Abnorm Psychol. 2005 Nov;114(4):560-4
16351379
Int J Methods Psychiatr Res. 2007;16 Suppl 1:S1-5
17623390
Psychiatr Serv. 1996 Aug;47(8):864-6
8837160
Am J Psychiatry. 2003 Aug;160(8):1373-84
12900295
Arch Gen Psychiatry. 1962 Dec;7:407-17
13931376
Nurs Res. 1989 Sep-Oct;38(5):286-8
2678015
Am J Psychiatry. 2007 Jun;164(6):859-60
17541042
J Nurs Scholarsh. 2003;35(2):177-82
12854300
JAMA. 1989 Aug 18;262(7):914-9
2754791
Acta Psychiatr Scand. 1994 Mar;89(3):152-8
8178672
Ann Intern Med. 1986 Sep;105(3):413-20
3740681
Aust N Z J Psychiatry. 2006 Aug;40(8):616-22
16866756
Ann Gen Psychiatry. 2006 Mar 23;5:4
16556313
Am J Psychiatry. 1986 Jul;143(7):904-7
3717432
Community Ment Health J. 1997 Feb;33(1):35-41
9061261
Acta Psychiatr Scand. 2007 Apr;115(4):326-30
17355524
Annu Rev Psychol. 1984;35:55-81
19368519
Health Technol Assess. 2003;7(1):1-76
12583822
Eur Child Adolesc Psychiatry. 2004 Oct;13(5):273-86
15490275
Health Technol Assess. 2001;5(31):1-256
11809125
Am J Psychiatry. 2000 Nov;157(11):1858-63
11058486
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
938196
Med Decis Making. 1983;3(4):477-87
6668992
Hosp Community Psychiatry. 1992 Jun;43(6):599-603
1601402
Soc Psychiatry Psychiatr Epidemiol. 1994 Sep;29(5):205-11
7992144
Psychol Rep. 2002 Dec;91(3 Pt 1):999-1006
12530758
Br J Psychiatry Suppl. 2003 Jan;44:S32-5
12509307
Tidsskr Nor Laegeforen. 2008 Jun 26;128(13):1541-3
18587464
Am J Med Qual. 1995 Fall;10(3):127-32
7549593
Community Ment Health J. 1990 Aug;26(4):335-44
2208964
Med Care. 1992 Jun;30(6):473-83
1593914
Am Psychol. 2000 Jan;55(1):5-14
11392865
Psychopathology. 1996 Nov-Dec;29(6):347-56
8994279
Psychol Bull. 2000 Nov;126(6):946-63
11107884
Inj Prev. 2008 Dec;14(6):401-4
19074247
Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000001
17443625
J Clin Psychol. 2000 Apr;56(4):449-61
10775040
Psychiatr Serv. 2005 Apr;56(4):439-43
15812094
Soc Psychiatry Psychiatr Epidemiol. 2007 Apr;42(4):322-7
17334898
Ann Intern Med. 1997 Apr 1;126(7):532-8
9092319
Am J Psychiatry. 1995 Sep;152(9):1386-8
7653701
Br J Psychiatry. 1995 May;166(5):654-9
7620753
Eff Clin Pract. 2001 Jul-Aug;4(4):157-62
11525102
Am J Psychiatry. 1992 Sep;149(9):1148-56
1386964
Int J Soc Psychiatry. 2002 Mar;48(1):11-9
12008903
Br J Med Psychol. 1999 Mar;72 ( Pt 1):127-34
10194578
Psychiatr Serv. 2005 Apr;56(4):434-8
15812093
Br J Psychiatry. 2005 Feb;186:146-52
15684239
Am Psychol. 2005 Jul-Aug;60(5):410-21
16045394
Psychiatr Serv. 2007 Apr;58(4):529-35
17412856
Psychiatr Serv. 2005 Apr;56(4):427-33
15812092
J Nerv Ment Dis. 1987 Jun;175(6):339-46
3585310
Br J Clin Psychol. 2002 Nov;41(Pt 4):417-22
12437796
Arch Gen Psychiatry. 1987 Sep;44(9):821-4
3632256
BMJ. 2005 Jan 8;330(7482):68
15619601
Compr Psychiatry. 2007 Jan-Feb;48(1):88-94
17145287
Psychiatr Serv. 2005 Apr;56(4):420-6
15812091
Psychiatr Serv. 2003 Jul;54(7):1028-30
12851442
BMJ. 1994 Sep 10;309(6955):648-51
8086990
BMC Med Res Methodol. 2005 Aug 10;5:24
16092960
Annu Rev Clin Psychol. 2007;3:29-51
17716047
Psychosomatics. 1995 May-Jun;36(3):267-75
7638314